Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16601 - 16625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Chromium	Approved Investigational	APOA1	335	upregulated	Chromium results in increased expression of APOA1 mRNA	11q23.3	A21640
Chromium	Approved Investigational	ARRDC3	57561	downregulated	Chromium results in decreased expression of ARRDC3 mRNA	5q14.3	A21641
Chromium	Approved Investigational	ASNS	440	upregulated	Chromium results in increased expression of ASNS mRNA	7q21.3	A20678
Chromium	Approved Investigational	ATP2B1	490	downregulated	Chromium results in decreased expression of ATP2B1 mRNA	12q21.33	A20678
Chromium	Approved Investigational	AZGP1	563	downregulated	Chromium results in decreased expression of AZGP1 mRNA	7q22.1	A20678
Chromium	Approved Investigational	BAX	581	upregulated	Chromium results in increased expression of BAX mRNA	19q13.33	A21642
Chromium	Approved Investigational	BBC3	27113	upregulated	Chromium results in increased expression of BBC3 mRNA	19q13.32	A21642
Chromium	Approved Investigational	BGN	633	downregulated	Chromium results in decreased expression of BGN mRNA	Xq28	A21641
Chromium	Approved Investigational	BHLHE40	8553	upregulated	Chromium results in increased expression of BHLHE40 mRNA	3p26.1	A20678
Chromium	Approved Investigational	CALR	811	downregulated	Chromium results in decreased expression of CALR mRNA	19p13.13	A20678
Chromium	Approved Investigational	CCNB2	9133	upregulated	Chromium results in increased expression of CCNB2 mRNA	15q22.2	A20678
Chromium	Approved Investigational	CD24	100133941	downregulated	Chromium results in decreased expression of CD24 mRNA	6q21	A21641
Chromium	Approved Investigational	CDKN1A	1026	downregulated	Chromium results in decreased expression of CDKN1A mRNA	6p21.2	A21642
Chromium	Approved Investigational	CDKN1A	1026	upregulated	Chromium results in increased expression of CDKN1A mRNA	6p21.2	A20678
Chromium	Approved Investigational	CFB	629	downregulated	Chromium results in decreased expression of CFB mRNA	6p21.33	A20678
Chromium	Approved Investigational	CHRDL1	91851	upregulated	Chromium results in increased expression of CHRDL1 mRNA	Xq23	A21641
Chromium	Approved Investigational	CHST3	9469	upregulated	Chromium results in increased expression of CHST3 mRNA	10q22.1	A20678
Chromium	Approved Investigational	CLGN	1047	downregulated	Chromium results in decreased expression of CLGN mRNA	4q31.1	A20678
Chromium	Approved Investigational	CLPTM1	1209	downregulated	Chromium results in decreased expression of CLPTM1 mRNA	19q13.32	A20678
Chromium	Approved Investigational	COL5A2	1290	downregulated	Chromium results in decreased expression of COL5A2 mRNA	2q32.2	A21641
Chromium	Approved Investigational	CPE	1363	downregulated	Chromium results in decreased expression of CPE mRNA	4q32.3	A21641
Chromium	Approved Investigational	CRISPLD2	83716	downregulated	Chromium results in decreased expression of CRISPLD2 mRNA	16q24.1	A21641
Chromium	Approved Investigational	CRYAA	1409	downregulated	Chromium results in decreased expression of CRYAA mRNA	21q22.3	A20678
Chromium	Approved Investigational	CX3CL1	6376	downregulated	Chromium results in decreased expression of CX3CL1 mRNA	16q21	A20678
Chromium	Approved Investigational	CXCL8	3576	upregulated	Chromium analog results in increased expression of CXCL8 mRNA	4q13.3	A20617

Displaying entries 16601 - 16625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability